The analysis of Global Chronic Obstructive Pulmonary Diseases (COPD) mortality highlights significant variations across countries. In 2023, the United States led with the highest mortality at 152.96 thousand deaths, while deaths were relatively lower in countries like Estonia and Iceland. Year-on-year variations indicate a general health trend: the United States showed a slight decline of 0.27%, Brazil increased by 1.48%, and Germany saw a decrease of 1.39%. Notably, countries like Colombia and Slovenia reported higher year-on-year increases of 4.19% and 5.74%, respectively, whereas Lithuania saw the highest decline at 9.6%. The overall trends indicate a mixed outlook depending on geography and healthcare advancements.
Future trends to watch include the impact of healthcare innovations and preventive care measures in reducing COPD mortality rates across countries. The effectiveness of public health policies and smoking cessation programs will play a crucial role, especially in countries with currently high mortality rates. Monitoring advancements in treatments and global health initiatives will be pivotal in addressing disparities and reducing the global burden of COPD.
Top countries in Chronic Obstructive Pulmonary Diseases Mortality by Country
| # | 10 Countries | Units (Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 152,960 | 2023 | +1% | -0.27% | View data |
| 2 | 2 Brazil | 48,940 | 2023 | +6.12% | +1.48% | View data |
| 3 | 3 Germany | 33,380 | 2023 | +0.63% | -1.39% | View data |
| 4 | 4 Mexico | 25,230 | 2023 | +0.62% | -0.55% | View data |
| 5 | 5 Colombia | 17,600 | 2023 | +6.2% | +4.19% | View data |
| 6 | 6 Canada | 13,010 | 2023 | +1.06% | +0.74% | View data |
| 7 | 7 Spain | 9,890 | 2023 | -1.36% | -5.41% | View data |
| 8 | 8 Australia | 7,760 | 2023 | +4.86% | +1.67% | View data |
| 9 | 9 Netherlands | 7,060 | 2023 | +4.66% | +0.5% | View data |
| 10 | 10 Argentina | 6,570 | 2023 | +6.64% | -0.13% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...